Weight LossMetabolicFDA Approved

Semaglutide

GLP-1 agonist

FDA-approved weight-loss powerhouse.

⚡ Fat Loss🎯 Appetite Control

Mechanism of Action

GLP-1 receptor agonist – slows gastric emptying, increases satiety.

Key Benefits

15–20%+ weight loss
Blood sugar control

Common Uses

ObesityType 2 diabetes

What to Expect

Onset

Appetite suppression within 24–48 hours of first dose; weight loss visible within 2–4 weeks

Duration

Effects last ~7 days per injection; weight loss is progressive and sustained over months

What Users Report

Dramatic reduction in 'food noise' — the constant background chatter about what to eat next simply disappears
Feeling full much faster during meals; portions naturally shrink to half or less
Some describe it as 'forgetting to eat' — food becomes fuel rather than a preoccupation
Nausea is common during the first 2–4 weeks, especially when titrating up; usually resolves
Food aversions can develop, particularly to greasy, fried, or very rich foods
A fundamentally calmer, healthier relationship with food — cravings for sugar and junk food fade
Significant, visible weight loss within 4–8 weeks that others start to notice
Some report reduced desire for alcohol as well

Typical Timeline

Days 1–2: Appetite suppression begins. Weeks 1–4: Titration period — nausea may occur, portion sizes naturally decrease. Weeks 4–8: Steady weight loss of 1–2+ lbs/week becomes consistent. Months 2–6: Major body transformation; 15–20%+ total weight loss is typical at maintenance dose. Ongoing: Continued weight management with sustained use.